Millennium Pharmacon International Cash Flow Conversion Efficiency

Latest as of June 2025: -0.063x

Millennium Pharmacon International cash flow conversion efficiency. Based on the latest financial reports, Millennium Pharmacon International (SDPC) has a cash flow conversion efficiency ratio of -0.063x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.67 Billion ≈ $-1.09 Million USD) by net assets (Rp296.69 Billion ≈ $17.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Millennium Pharmacon International (2004–2024)

Cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024. This chart illustrates how Millennium Pharmacon International's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Millennium Pharmacon International share price for real-time trading data and today's change.

Millennium Pharmacon International Cash Flow Conversion Ratio Explained

Millennium Pharmacon International cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Millennium Pharmacon International Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Millennium Pharmacon International ranked by their cash flow conversion efficiency. Also see Millennium Pharmacon International (SDPC) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Energys Group Limited Ordinary Shares
NASDAQ:ENGS
N/A
OYAK Yatirim Ortakligi AS
IS:OYAYO
-0.012x
Shanghai Supezet Engineering Technology Corp Ltd
SHG:688121
-0.016x
CEKD Bhd
KLSE:0238
0.024x
Vision Sigma
TA:VISN
-0.017x
Triton Holding Public Company Limited
BK:TRITN
-0.010x
Donegal Investment Group PLC
IR:DQ7A
-0.234x
Magnum Mining and Exploration Ltd
AU:MGU
-0.164x

Annual Cash Flow Conversion Efficiency for Millennium Pharmacon International (2004–2024)

The table below shows the annual cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024. Review Millennium Pharmacon International free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp282.50 Billion
≈ $16.55 Million
Rp-125.45 Billion
≈ $-7.35 Million
-0.444x -34.56%
2023-12-31 Rp277.71 Billion
≈ $16.27 Million
Rp-91.65 Billion
≈ $-5.37 Million
-0.330x -308.43%
2022-12-31 Rp258.91 Billion
≈ $15.17 Million
Rp41.00 Billion
≈ $2.40 Million
0.158x +306.44%
2021-12-31 Rp236.98 Billion
≈ $13.89 Million
Rp-18.18 Billion
≈ $-1.07 Million
-0.077x -124.52%
2020-12-31 Rp229.20 Billion
≈ $13.43 Million
Rp71.69 Billion
≈ $4.20 Million
0.313x +391.54%
2019-12-31 Rp235.44 Billion
≈ $13.80 Million
Rp-25.26 Billion
≈ $-1.48 Million
-0.107x -627.27%
2018-12-31 Rp232.11 Billion
≈ $13.60 Million
Rp4.72 Billion
≈ $276.75K
0.020x -2.94%
2017-12-31 Rp212.61 Billion
≈ $12.46 Million
Rp4.46 Billion
≈ $261.18K
0.021x +111.13%
2016-12-31 Rp143.28 Billion
≈ $8.40 Million
Rp-26.99 Billion
≈ $-1.58 Million
-0.188x +63.20%
2015-12-31 Rp134.31 Billion
≈ $7.87 Million
Rp-68.74 Billion
≈ $-4.03 Million
-0.512x -1218.86%
2014-12-31 Rp121.79 Billion
≈ $7.14 Million
Rp-4.73 Billion
≈ $-276.93K
-0.039x +91.69%
2013-12-31 Rp114.87 Billion
≈ $6.73 Million
Rp-53.67 Billion
≈ $-3.14 Million
-0.467x -2326.94%
2012-12-31 Rp104.62 Billion
≈ $6.13 Million
Rp2.19 Billion
≈ $128.61K
0.021x +118.58%
2011-12-31 Rp94.78 Billion
≈ $5.55 Million
Rp-10.70 Billion
≈ $-626.92K
-0.113x -273.40%
2007-12-31 Rp70.24 Billion
≈ $4.12 Million
Rp4.57 Billion
≈ $267.94K
0.065x +391.77%
2006-12-31 Rp60.63 Billion
≈ $3.55 Million
Rp802.62 Million
≈ $47.03K
0.013x -78.04%
2004-12-31 Rp45.18 Billion
≈ $2.65 Million
Rp2.72 Billion
≈ $159.57K
0.060x --

About Millennium Pharmacon International

JK:SDPC Indonesia Medical Distribution
Market Cap
$13.66 Million
Rp233.14 Billion IDR
Market Cap Rank
#26077 Global
#561 in Indonesia
Share Price
Rp183.00
Change (1 day)
-6.15%
52-Week Range
Rp137.00 - Rp208.00
All Time High
Rp357.65
About

PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more